Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age

被引:39
作者
Ray, Paula [1 ]
Black, Steven [2 ]
Shinefield, Henry [3 ]
Dillon, Aileen [4 ]
Carpenter, Diane [5 ]
Lewis, Edwin [1 ]
Ross, Pat [1 ]
Chen, Robert T. [6 ]
Klein, Nicola P. [1 ]
Baxter, Roger [1 ]
机构
[1] Kaiser Permanente, Vaccine Study Ctr, Oakland, CA 94612 USA
[2] Univ Cincinnati, Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA
[3] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[4] Permanente Med Grp Inc, San Francisco, CA USA
[5] Kaiser Permanente, Div Res, Oakland, CA USA
[6] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
Vaccine; Adverse; Rheumatoid; Arthritis; Vaccination; Hepatitis B; Tetanus; Influenza; GUILLAIN-BARRE-SYNDROME; RUBELLA IMMUNIZATION; ADULTS; MANIFESTATIONS; EPIDEMIOLOGY; DISEASES; WOMEN;
D O I
10.1016/j.vaccine.2011.06.112
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Associations between vaccinations, particularly hepatitis B, and onset of rheumatoid arthritis (RA) have been reported, but examined in few large-scale studies. Method: Onset of RA cases and dates of vaccination against hepatitis B, tetanus, and influenza were identified in a retrospective chart review of approximately 1 million Kaiser Permanente Northern California members ages 15-59 years from 1997 through 1999. In a cohort analysis, rates of new-onset RA were compared between vaccinated and unvaccinated within 90, 180, and 365 days. In a case-control analysis, rates of vaccination during exposure intervals (90, 180, 365, and 730 days) were compared between cases and controls using conditional logistic regression. Results: 378 RA cases were included in the cohort analysis; 37 additional cases were included in the case-control analysis. In the cohort analysis the relative risks of RA onset within 90, 180, or 365 days of hepatitis B vaccination were not significant (R.R. = 1.44, p = 0.53; R.R. = 1.67, p = 0.22; R.R. = 1.23, p = 0.59 respectively). We found a possible association between RA and influenza vaccine in the previous 180 and 365 days in the cohort analysis (R.R = 1.36, p = 0.03; R.R. = 1.34, p = 0.01 respectively), but in the case-control analysis, cases were no more likely than controls to have received any of the three vaccines. Conclusions: In this large retrospective study we found no statistically significant association between exposure to hepatitis B vaccine and onset of RA. A possible association between RA and influenza vaccination in the cohort study was not borne out in the larger case-control analysis. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6592 / 6597
页数:6
相关论文
共 10 条
  • [1] Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States
    Lu, Peng-jun
    Euler, Gary L.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2011, 39 (06) : 488 - 494
  • [2] Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years
    Fair, E
    Murphy, TV
    Golaz, A
    Wharton, M
    PEDIATRICS, 2002, 109 (01) : E2
  • [3] Benefits of influenza vaccination among healthy and high-risk persons across the age spectrum
    Nichol, KL
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 48 - 50
  • [4] Vaccination coverage and predictors of influenza, pneumococcal, herpes zoster, tetanus, measles, and hepatitis B vaccine uptake among adults in Greece
    Tsiligianni, I.
    Bouloukaki, I
    Papazisis, G.
    Paganas, A.
    Chatzimanolis, E.
    Kalatharas, M.
    Platakis, I.
    Tirodimos, I.
    Dardavesis, T.
    Tsimtsiou, Z.
    PUBLIC HEALTH, 2023, 224 : 195 - 202
  • [5] Persistence of hepatitis B immune memory until 9-10years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP≈T vaccination at 2, 4 and 6 months
    Kosalaraksa, Pope
    Chokephaibulkit, Kulkanya
    Benjaponpitak, Suwat
    Pancharoen, Chitsanu
    Chuenkitmongkol, Sunate
    B'Chir, Siham
    Da Costa, Xavier
    Vidor, Emmanuel
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) : 1257 - 1265
  • [6] Persistence of hepatitis B surface antibody until 7 years of age following administration of hexavalent and pentavalent vaccines in children at 2, 4, 6, and 18 months
    Wanlapakorn, Nasamon
    Sarawanangkoor, Nasiri
    Srimuan, Donchida
    Thatsanathorn, Thaksaporn
    Klinfueng, Sirapa
    Poovorawan, Yong
    VACCINE: X, 2024, 20
  • [7] Hepatitis B vaccination coverage among high-risk adults 18-49 years, US, 2009
    Lu, Peng-jun
    Byrd, Kathy K.
    Murphy, Trudy V.
    Weinbaum, Cindy
    VACCINE, 2011, 29 (40) : 7049 - 7057
  • [8] Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP∼T Vaccination in a 3-, 5-and 11-to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination
    Virta, Miia
    Soininen, Anu
    Patel, Dhaval M.
    Petit, Celine
    Tabar, Cynthia
    Lyabis, Olga
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (01) : E28 - E30
  • [9] Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions-United States, 2010
    Lu, Peng-jun
    Gonzalez-Feliciano, Amparo
    Ding, Helen
    Bryan, Leah N.
    Yankey, David
    Monsell, Elizabeth A.
    Greby, Stacie M.
    Euler, Gary L.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (08) : 702 - 709
  • [10] Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3,5 and 11-12 months of age
    Avdicova, Maria
    Crasta, Priya D.
    Hardt, Karin
    Kovac, Martina
    VACCINE, 2015, 33 (23) : 2727 - 2733